IDEAS home Printed from https://ideas.repec.org/a/gam/jijfss/v13y2025i1p43-d1605751.html
   My bibliography  Save this article

Capital Structure Decisions in Swedish Biotechnology Firms: The Role of Intellectual Capital and Innovation Activities

Author

Listed:
  • Kritthana Kimuam

    (Department of Real Estate and Construction Management, KTH Royal Institute of Technology, 10044 Stockholm, Sweden)

  • Björn Berggren

    (Department of Real Estate and Construction Management, KTH Royal Institute of Technology, 10044 Stockholm, Sweden)

  • Ida Ayu Agung Faradynawati

    (Department of Real Estate and Construction Management, KTH Royal Institute of Technology, 10044 Stockholm, Sweden)

Abstract

Biotechnology firms operate in a highly innovative and capital-intensive environment, characterized by high levels of R&D, long product development periods, significant regulations, and high levels of uncertainty. These firms rely heavily on intangible assets, such as intellectual capital and innovation. Consequently, intellectual capital and innovation activities play a crucial role in financial strategies and capital structure decisions. This study aims to examine how intellectual capital and innovation activity influence capital structure decisions of biotech firms in Sweden. In this paper, financial data of 1528 companies from 2012 to 2022 were analyzed. Using logistic regression modeling, the results showed that biotech firms with higher intellectual capital are more likely to issue equity whereas those with greater innovation activity tend to rely more on debt financing. These findings underscore the complexities of financial strategy in the biotech sector, emphasizing the need for flexible capital structure management. Moreover, policymakers should focus not only on equity availability but also on ensuring access to debt financing, as both are crucial for sustaining biotech innovation and growth.

Suggested Citation

  • Kritthana Kimuam & Björn Berggren & Ida Ayu Agung Faradynawati, 2025. "Capital Structure Decisions in Swedish Biotechnology Firms: The Role of Intellectual Capital and Innovation Activities," IJFS, MDPI, vol. 13(1), pages 1-16, March.
    • Handle: RePEc:gam:jijfss:v:13:y:2025:i:1:p:43-:d:1605751
    as

    Download full text from publisher

    File URL: https://www.mdpi.com/2227-7072/13/1/43/pdf
    Download Restriction: no
    File URL: https://www.mdpi.com/2227-7072/13/1/43/
    Download Restriction: no
    ---><---

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:gam:jijfss:v:13:y:2025:i:1:p:43-:d:1605751. See general information about how to correct material in RePEc.

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    We have no bibliographic references for this item. You can help adding them by using this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: MDPI Indexing Manager (email available below). General contact details of provider: https://www.mdpi.com .

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.